The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

Tricaprin     2,3-didecanoyloxypropyl decanoate

Synonyms: Tridecanoin, tri-Decanoin, tri-n-Caprin, Dynasan 110, Decanoin, tri-, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

High impact information on Caprin

 

Associations of Caprin with other chemical compounds

  • The purpose of this study was to investigate the effect of 2 additives, poly(ethylene glycol) (PEG) 1000 and 1,2,3-tridecanoyl glycerol (tricaprin), on the physico-chemical characteristics and in vitro release of a model protein, bovine serum albumin (BSA), form poly(D,L-lactic-co-glycolic acid) (PLGA) microspheres [6].
 

Gene context of Caprin

  • Tricaprylin (C8), tricaprin (C10), a mixture of C8 and C10 (mixed MCT) or soya oil were given at 11-18 days of age [7].
 

Analytical, diagnostic and therapeutic context of Caprin

  • The percentage of tricaprin used did not significantly affect the drug loading efficiency of the microspheres [8].
  • The plasma TG level, on the other hand, increased from 11.9 to 19.2 mmol/l (+61%) at 6 h after loading a fatty meal containing LCT, whereas the plasma TG levels tended to even decrease at 6 h after oral administration of an MCT, tricaprin (from 11.6 to 10.5 mmol/l (-9.4%)) [9].

References

  1. Histological effects of lipids on the liver and spleen of mice. Stuart, A.E., Smith, I.I. J. Pathol. (1975) [Pubmed]
  2. Effects of simple lipids on macrophages in vitro. Smith, I.I., Stuart, A.E. J. Pathol. (1975) [Pubmed]
  3. Gastric emptying in rats following administration of a range of different fats measured as acetaminophen concentration in plasma. Porsgaard, T., Straarup, E.M., Høy, C.E. Ann. Nutr. Metab. (2003) [Pubmed]
  4. An improved GLC method for a rapid, simultaneous analysis of both medium chain fatty acids and medium chain triglycerides in plasma. Mingrone, G., Greco, A.V., Capristo, E., Benedetti, G., Castagneto, M., Gasbarrini, G. Clin. Chim. Acta (1995) [Pubmed]
  5. Type I hyperlipoproteinemia caused by lipoprotein lipase defect in lipid-interface recognition was relieved by administration of medium-chain triglyceride. Shirai, K., Kobayashi, J., Inadera, H., Ohkubo, Y., Mori, S., Saito, Y., Yoshida, S. Metab. Clin. Exp. (1992) [Pubmed]
  6. Effect of additives on the release of a model protein from PLGA microspheres. Kang, F., Singh, J. AAPS PharmSciTech [electronic resource]. (2001) [Pubmed]
  7. Plasma ketone levels in neonatal calves fed medium chain triglycerides in milk. Sato, H. J. Vet. Med. Sci. (1994) [Pubmed]
  8. Effect of tricaprin on the physical characteristics and in vitro release of etoposide from PLGA microspheres. Schaefer, M.J., Singh, J. Biomaterials (2002) [Pubmed]
  9. A novel frameshift mutation in exon 6 (the site of Asn 291) of the lipoprotein lipase gene in type I hyperlipidemia. Kobayashi, J., Nagashima, I., Taira, K., Hikita, M., Tamura, K., Bujo, H., Morisaki, N., Saito, Y. Clin. Chim. Acta (1999) [Pubmed]
 
WikiGenes - Universities